Medtronic touts 1st enrollment in Reality PAD study
Medtronic (NYSE:MDT) said yesterday it enrolled the 1st patients in the VIVA-sponsored Reality study assessing outcomes of peripheral artery disease patients treated with directional atherectomy and...
View ArticleWomen’s health focused NVision Medical raises $12m in Series B
Stealthy NVision Medical has raised $12 million in Series B financing, with funds slated to support product development, clinical studies and regulatory submissions to for its micro-catheter...
View ArticleFrom discovery to delivery: Moving academic innovations to the market
“Wouldn’t it be great if we could come up with a noninvasive diagnostic assay to detect pancreatic cancer at an earlier, more treatable stage?” asked Lori Aro of Myriad Genetics. Her company has been...
View ArticleAlign Tech releases street-beating Q2, announces deal with SmileDirectClub
Align Technology (NSDQ:ALGN) yesterday released its 2nd quarter earnings, handily beating the street on revenue and earnings per share and announcing a new agreement with SmileDirectClub. The reported...
View ArticleSPR Therapeutics wins FDA nod for peripheral nerve stim pain relief device
Pain management company SPR Therapeutics yesterday said it won FDA 510(k) clearance for its Sprint peripheral nerve stimulation system designed to provide chronic pain relief. The Cleveland, Ohio-based...
View ArticleCareFusion recalls select AVEA ventilators over electrical issues
The FDA yesterday released information on a select recall of CareFusion AVEA Ventilators due to electrical issues which could cause unexpected shutdowns. The federal watchdog labeled the recall as a...
View ArticleTactile Systems reduces IPO to $46m
Leg compression device developer Tactile Systems Technology reduced its initial public offering to $46 million. Those estimates are down approximately 24% from the $60 million it said it hoped to bring...
View ArticleBioVentus delays $150m IPO
Orthobiologics maker Bioventus postponed its initial public offering which was slated to raise up to $150 million for the company, according to Renaissance Capital. The company plans to float 8.8...
View ArticleResMed shares lift on solid Q4 posting
ResMed (NYSE:RMD) yesterday released 4th quarter earnings that beat the Street and sent shares up, despite missing on fiscal year 2016 expectations. For the quarter, ResMed reported profits of $83.1...
View ArticleVytronUS raises $49m to support cardiac mapping & ablation system
Cardiac mapping & ablation system developer VytronUS said today it raised $49 million in a Series C round of equity financing. Funds from the round will go to support technology refinements and...
View ArticleMicro Interventional Devices wins FDA nod for Permaseal
Micro Interventional Devices said today it won FDA 510(k) clearance for its Permaseal transapical access and closure device. The Permaseal device is designed to allow surgeons to access and close the...
View ArticleMedtronic touts 5-year Endurant stent graft data
More than 5 years after Medtronic‘s (NYSE:MDT) Endurant Stent Graft System 1st gained FDA approval, the medical device giant has released data pointing to long-term durability of the treatment for...
View ArticleMassDevice.com +5 | The top 5 medtech stories for July 29, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleFormer AcuFocus CEO Mazzo moves to head Ophthamology at Zeiss | Personnel...
Former AcuFocus CEO Mazzo moves to head Ophthamology at Zeiss Carl Zeiss Meditec (ETR:AFX) said this week it tapped ex-AcuFocus CEO James Mazzo as the global president of its ophthalmology business as...
View ArticleTechnology alone may not close disparities in medical research
(Reuters) – Internet technologies may help underserved populations participate in medical research studies, but relying on those technologies to get broader participation isn’t likely to work, a new...
View ArticleAlcon wins FDA nod for CyPass Micro-Stent
Novartis (NYSE:NVS)’s Alcon unit won FDA clearance for its CyPass Micro-stent designed to reduce intraocular pressure in patients suffering from glaucoma, according to an FDA release posted today. The...
View ArticleIntersect ENT files with FDA for drug-delivering sinus implant
Intersect ENT (NSDQ:XENT) said today it submitted a supplemental premarket approval submission to the FDA seeking approval for a new Nova steroid releasing implant for treating patients with chronic...
View ArticlePhilips releases set of connected mobile health tools
Royal Philips (NYSE:PHG) today announced the launch of a series of connected personal health devices , including a health monitoring watch, scale, blood pressure monitor and thermometer, all designed...
View ArticleMedtronic wins expanded CE Mark for Evolut R TAVR system
Medtronic (NYSE:MDT) said today it won expanded CE Mark approval in the European Union for its CoreValve Evolut R transcatheter aortic valve replacement, now approved for aortic stenosis patients at...
View ArticleHaemonetics sees shares rise on Q1 release
Haemonetics (NYSE:HAE) has seen shares rise despite releasing 1st quarter earnings that saw losses grow and earnings per share shrink compared to last year. The Braintree, Mass.-based company reported...
View Article